Innovations

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

0
A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration

Patients with a type of breast cancer called HER2-positive are less likely to survive if their initial treatment fails to eradicate the tumor completely and they have high levels of immune cells called tumor infiltrating lymphocytes in the residual disease.

Best mattress deals as of Nov. 17: Save on popular brands like Casper and more

Previous article

Time-restricted eating reduces body mass in young athletic men

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations